Vastatin (the NC1 domain of human type VIII collagen a1 chain) is linked to stromal reactivity and elevated in serum from patients with colorectal cancer

References

• Farnsworth RH, Lackmann M, Achen MG, Stacker SA. Vascular remodeling in cancer. Oncogene. 2014;33:3496–3505. doi:10.1038/onc.2013.304.
   PubMed Web of Science ®Google Scholar
• Ciombor KK, Goldberg RM. Update on anti-angiogenesis therapy in colorectal cancer. Curr Colorectal Cancer Rep. 2015;11:378–387. doi:10.1007/s11888-015-0292-3.
   PubMed Web of Science ®Google Scholar
• Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer. 2003;3:422–433. doi:10.1038/nrc1094.
   PubMed Web of Science ®Google Scholar
• Lu P, Takai K, Weaver VM, Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. 2011;3:12.
   Web of Science ®Google Scholar
• Kehlet SN, Sanz-Pamplona R, Brix S, Leeming DJ, Karsdal MA, Moreno V. Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients. Sci Rep. 2016;6:30599.
   PubMed Web of Science ®Google Scholar
• Mortensen JH, Godskesen LE, Jensen MD, Van Haaften WT, Klinge LG, Olinga P, Dijkstra G, Kjeldsen J, Karsdal MA, Bay-Jensen AC, et al. Fragments of citrullinated and MMP-degraded Vimentin and MMP-degraded type III Collagen are novel serological biomarkers to differentiate Crohn’s disease from ulcerative colitis. J Crohns Colitis. 2015;9:863–872.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Nielsen SH, Leeming DJ, Langholm LL, Nielsen MJ, Manon-Jensen T, Siebuhr A, Gudmann NS, Rønnow S, Sand JM, et al. The good and the bad collagens of fibrosis - Their role in signaling and organ function. Adv Drug Deliv Rev. 2017;121:43–56.
   PubMed Web of Science ®Google Scholar
• O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277–285.
   PubMed Web of Science ®Google Scholar
• Kantola T, Väyrynen JP, Klintrup K, Mäkelä J, Karppinen SM, Pihlajaniemi T, Autio-Harmainen H, Karttunen TJ, Mäkinen MJ, Tuomisto A. Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers. Br J Cancer. 2014;111:1605–1613.
   PubMed Web of Science ®Google Scholar
• Sibinga NE, Foster LC, Hsieh CM, Perrella MA, Lee WS, Endege WO, Sage EH, Lee ME, Haber E. Collagen VIII is expressed by vascular smooth muscle cells in response to vascular injury. Circ Res. 1997;80:532–541.
   PubMed Web of Science ®Google Scholar
• Xu R, Yao Z-Y, Xin L, Zhang Q, Li T-P, Gan R-B. NC1 domain of human type VIII collagen (alpha 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis. Biochem Biophys Res Commun. 2001;289:264–268. doi:10.1006/bbrc.2001.5970.
   PubMed Web of Science ®Google Scholar
• Li X, Wang Z, Tong H, Yan Y, Li S. Effects of COL8A1 on the proliferation of muscle-derived satellite cells. Cell Biol Int. 2018;42:1132–1140. doi:10.1002/cbin.v42.9.
   Web of Science ®Google Scholar
• Li Y, Li J, Woo YM, Shen Z, Yao H, Cai Y, Lin MC, Poon WS. Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model. BMC Cancer. 2017;17:126. doi:10.1186/s12885-017-3125-8.
   PubMed Web of Science ®Google Scholar
• Ma ZH, Ma JH, Jia L, Zhao YF. Effect of enhanced expression of COL8A1 on lymphatic metastasis of hepatocellular carcinoma in mice. Exp The Med. 2012;4:621–626. doi:10.3892/etm.2012.652.
   PubMed Web of Science ®Google Scholar
• Koon N, Schneider-Stock R, Sarlomo-Rikala M, Lasota J, Smolkin M, Petroni G, Zaika A, Boltze C, Meyer F, Andersson L, et al. Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut. 2004;53:235–240. doi:10.1136/gut.2003.021238.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Jia L, Mao X, Xu H, Wang B, Liu Y. siRNA-targeted COL8A1 inhibits proliferation, reduces invasion and enhances sensitivity to D-limonence treatment in hepatocarcinoma cells. IUBMB Life. 2009;61:74–79. doi:10.1002/iub.v61:1.
   PubMed Web of Science ®Google Scholar
• Hansen NUB, Willumsen N, Sand JMB, Larsen L, Karsdal MA, Leeming DJ. Type VIII collagen is elevated in diseases associated with angiogenesis and vascular remodeling. Clin Biochem. 2016;49:903–908. doi:10.1016/j.clinbiochem.2016.05.023.
   PubMed Web of Science ®Google Scholar
• Willumsen N, Bager C, Bay‑Jensen A, Kehlet S, Harling H, Leeming D, Karsdal M, Jorgensen L. Unique insight into microenvironmental changes in colorectal cancer: exï vivo assessment of matrix metalloprotease‑mediated molecular changes in human colorectal tumor tissue and corresponding non‑neoplastic adjacent tissue. Oncol Lett. 2017;13:3774–3780. doi:10.3892/ol.2017.5900.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Genovese F, Madsen EA, Manon-Jensen T, Schuppan D. Collagen and tissue turnover as a function of age: implications for fibrosis. J Hepatol. 2016;64:103–109. doi:10.1016/j.jhep.2015.08.014.
   PubMed Web of Science ®Google Scholar
• Kehlet SN, Willumsen N, Armbrecht G, Dietzel R, Brix S, Henriksen K, Karsdal MA. Age-related collagen turnover of the interstitial matrix and basement membrane: implications of age- and sex-dependent remodeling of the extracellular matrix. PLoS ONE. 2018;13:e0194458. doi:10.1371/journal.pone.0194458.
   PubMed Web of Science ®Google Scholar
• Mitsuma W, Kodama M, Hanawa H, Ito M, Ramadan MM, Hirono S, Obata H, Okada S, Sanada F, Yanagawa T, et al. Serum endostatin in the coronary circulation of patients with coronary heart disease and its relation to coronary collateral formation. Am J Cardiol. 2007;99:494–498. doi:10.1016/j.amjcard.2006.09.095.
   PubMed Web of Science ®Google Scholar
• Carlsson AC, Ruge T, Sundstrom J, Ingelsson E, Larsson A, Lind L, Arnlov J. Association between circulating endostatin, hypertension duration, and hypertensive target-organ damage. Hypertension. 2013;62:1146–1151. doi:10.1161/HYPERTENSIONAHA.113.02250.
   PubMed Web of Science ®Google Scholar
• Piccirillo JF, Vlahiotis A, Barret LB, Flood KL, Spitznagel EL Jr., Steyerberg EW. The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol. 2008;67:124–132. doi:10.1016/j.critrevonc.2008.01.013.
   PubMed Web of Science ®Google Scholar
• Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, Vieth M, Hoefler G, Langner C. Intramural and extramural vascular invasion in colorectal cancer. Cancer. 2012;118:628–638. doi:10.1002/cncr.26523.
   PubMed Web of Science ®Google Scholar
• Shang J, Wang F, Chen P, Wang X, Ding F, Liu S, Zhao Q. Co-expression network analysis identified COL8A1 is associated with the progression and prognosis in human colon adenocarcinoma. Dig Dis Sci. 2018;63:1219–1228. doi:10.1007/s10620-018-4996-5.
   PubMed Web of Science ®Google Scholar
• Döring G. The role of neutrophil Elastase in chronic inflammation. Am J Respir Crit Care Med. 1994;150:S114–7. doi:10.1164/ajrccm.150.5.7832867.
   PubMed Web of Science ®Google Scholar
• Kittelberger R, Neale TJ, Francky KT, Greenhill NS, Gibson GJ. Cleavage of type VIII collagen by human neutrophil elastase. BBA - Mol Basis Dis. 1992;1139:295–299. doi:10.1016/0925-4439(92)90103-T.
   PubMedGoogle Scholar
• Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol. 2013;33:79–84.
   Web of Science ®Google Scholar
• Vong S, Kalluri R. The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis. Genes Cancer. 2011;2:1139–1145. doi:10.1177/1947601911423940.
   PubMedGoogle Scholar
• van Haaften WT, Mortensen JH, Karsdal MA, Bay-Jensen AC, Dijkstra G, Olinga P. Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn’s disease. Aliment Pharmacol Ther. 2017;46:26–39. doi:10.1111/apt.14092.
   PubMed Web of Science ®Google Scholar
• Bay-Jensen AC, Guo X, Mortensen JH, Karsdal MA. VICM is a novel biomarker of macrophage activity evaluated in a phase IIb clinical trial of mavrilimumab. Arthritis Rheumatol. 2015;67(suppl):10.
   Google Scholar
• Ono M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 2008;99:1501–1506. doi:10.1111/j.1349-7006.2008.00853.x.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Nielsen MJ, Sand JM, Henriksen K, Genovese F, Bay-Jensen A-C, Smith V, Adamkewicz JI, Christiansen C, Leeming DJ. Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure. Assay Drug Dev Technol. 2013;11:70–92. doi:10.1089/adt.2012.474.
   PubMed Web of Science ®Google Scholar
• Egeblad M, Rasch MG, Weaver VM. Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol. 2010;22:697–706. doi:10.1016/j.ceb.2010.08.015.
   PubMed Web of Science ®Google Scholar
• Cox TR, Erler JT. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech. 2011;4:165–178. doi:10.1242/dmm.004077.
   PubMed Web of Science ®Google Scholar
• Adiguzel E, Hou G, Sabatini PJB, Bendeck MP. Type VIII collagen signals via β1 integrin and RhoA to regulate MMP-2 expression and smooth muscle cell migration. Matrix Biol. 2013;32:332–341. doi:10.1016/j.matbio.2013.03.004.
   PubMed Web of Science ®Google Scholar
• Hou G, Mulholland D, Gronska MA, Bendeck MP. Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury. Am J Pathol. 2000;156:467–476. doi:10.1016/S0002-9440(10)64698-6.
   PubMed Web of Science ®Google Scholar
• Lopes J, Adiguzel E, Gu S, Liu SL, Hou G, Heximer S, Assoian RK, Bendeck MP. Type VIII collagen mediates vessel wall remodeling after arterial injury and fibrous cap formation in atherosclerosis. Am J Pathol. 2013;182:2241–2253. doi:10.1016/j.ajpath.2013.02.011.
   PubMed Web of Science ®Google Scholar
• Lopes J, Hou G, Bendeck M. Type VIII collagen mediates atherosclerotic plaque development and fibrous cap formation. Can J Cardiol. 2013;29:S171. doi:10.1016/j.cjca.2013.07.262.
   Web of Science ®Google Scholar
• Binion DG, Rafiee P. Is inflammatory bowel disease a vascular disease? Targeting angiogenesis improves chronic inflammation in inflammatory bowel disease. Gastroenterology. 2009;136:400–403. doi:10.1053/j.gastro.2008.12.029.
   PubMed Web of Science ®Google Scholar
• Kim ER, Chang DK. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. World J Gastroenterol. 2014;20:9872.
   PubMed Web of Science ®Google Scholar
• Botrel TEA, Clark LG de O, Paladini L, Clark OAC. Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis. BMC Cancer. 2016;16:677.
   PubMed Web of Science ®Google Scholar
• Gladbender J, Cooney E, Kandel J, Yamashiro D. Vascular remodeling and clinical resistance to antiangiogenic cancer therapy. Drug Resist Updat. 2004;7:289–300.
   PubMed Web of Science ®Google Scholar
• Qian C-N, Tan M-H, Yang J-P, Cao Y. Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation. Chin J Cancer. 2016;35:10.
   PubMed Web of Science ®Google Scholar
• Rahbari NN, Kedrin D, Incio J, Liu H, Ho WW, Nia HT, Edrich CM, Jung K, Daubriac J, Chen I, et al. Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases. Sci Transl Med. 2016;8:360.
   Web of Science ®Google Scholar
• Vasudev NS, Reynolds AR. Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis. 2014;17:471–494.
   PubMed Web of Science ®Google Scholar
• Edge S, Compton C. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–1474.
   PubMed Web of Science ®Google Scholar
• Barascuk N, Veidal SS, Larsen L, Larsen DV, Larsen MR, Wang J, Zheng Q, Xing R, Cao Y, Rasmussen LM, et al. A novel assay for extracellular matrix remodeling associated with liver fibrosis: an enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochem. 2010;43:899–904.
   PubMed Web of Science ®Google Scholar
• Vassiliadis E, Oliveira CP, vares-da-Silva MR, Zhang C, Carrilho FJ, Stefano JT, Rabelo F, Pereira L, Kappel CR, Henriksen K, et al. Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology. Am J Transl Res. 2012;4:403–414.
   PubMed Web of Science ®Google Scholar